Not first choice: Look, we are in a new age of treatment, and need to acknowledge that the older injectables were great to use, but the drugs you listed are far more effective, and avoid needles (except tysabri, (natalizumab) one infusion monthly) yet, risks are present with all three, and in comparison with rebif, absence of long-term safety data. If you are doing well, could stay on current med, but change if MRI is active.
Answered 9/24/2014
5k views
7 doctors weighed in across 3 answers
4 doctors weighed in across 3 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question